Skip to content
Lower risk Medical device recall · FDA · Published March 30, 2022

Medtronic Vanta INS Implantable Neurostimulator: Communication Issues with Programming

Medtronic recalls Vanta INS Implantable Neurostimulators with AdaptiveStim Technology that may not communicate properly with clinical or patient programming systems. Affected models include specific serial numbers and expiration dates listed in the recall notice.

🇺🇸 FDA recall #Z-1123-2022Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic Neuromodulation7000 Central Ave Ne · Minneapolis, MN 55432-3568
✎ GovInfoNow plain-language explainer

What happened, in plain English

Medtronic is recalling Vanta INS Implantable Neurostimulators with AdaptiveStim Technology that may not communicate with programming systems. This could lead to improper pain management settings being applied. Affected devices have specific serial numbers and expiration dates listed in the recall notice. Read more at govinfonow.com/recall/60864-medtronic-vanta-ins-implantable-neurostimulator-communication-issues-with-programming-systems.

Source Summary by GovInfoNow · govinfonow.com/recall/60864-medtronic-vanta-ins-implantable-neurostimulator-communication-issues-with-programming-systems · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1123-2022

Cite this page

“Medtronic Vanta INS Implantable Neurostimulator: Communication Issues with Programming.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60864-medtronic-vanta-ins-implantable-neurostimulator-communication-issues-with-programming-systems. Based on FDA recall #Z-1123-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1123-2022%22&limit=1).

Why it’s dangerous

The implantable neurostimulator may not communicate properly with clinical or patient programming systems, which could result in improper pain management settings being applied. This is a software communication issue rather than a physical hazard.

Who’s affected

Patients using Medtronic Vanta INS Implantable Neurostimulators with AdaptiveStim Technology for pain therapy are most at risk. The recall affects specific serial numbers and expiration dates listed in the notice.

How to tell if you have this one

Check your device's serial numbers against the list provided in the recall notice. The affected models include specific serial numbers with expiration dates from March 2023 through October 2023.

  • Brand
    Medtronic
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Serial Numbers

    Compare your device's serial numbers with the list of affected serial numbers provided in the recall notice (e.g., NMS500202H, NMS500236H, etc.).

  2. Contact Medtronic

    If your device is listed, contact Medtronic directly for further instructions on how to proceed with the recall.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 47 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, ND, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Mar 30, 202212. FDA classified it Class II: May 23, 202223. Published in FDA’s Enforcement Report: Jun 1, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1123-2022 (March 30, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1123-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA